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Background
Hematological manifestations are frequently seen in sys-
temic lupus erythematosus (SLE). Anaemia, leucopenia
and thrombocytopenia may result from bone marrow
failure or excessive peripheral cell destruction, both of
which may be immune mediated. Anaemia is a common
manifestation in patients with systemic lupus erythema-
tosus. The most common forms of anaemia, in these
patients, are autoimmune hemolytic anemia (AHA), iron-
deficiency anaemia (IDA), anaemia of chronic disease
(ACD), drug-induced myelotoxicity, anaemia of chronic
renal failure and rarely types such as pure red cell aplasia,
B12 deficiency anemia and myelofibrosis.
Aim of study
To evaluate the types of anaemia in systemic lupus
erythematosus and their association with activity of the
disease and their impact in quality of life.
Methods
We examined 86 SLE patients by ACR, 1997 criteria, from
them 59 were with hematological abnormalities. Disease
duration was calculated from the time at least four and
more ACR criteria were fulfilled. Anti-ds DNA antibodies,
erythropoietin and ferritin levels were measured at base-
line. Disease activity was assessed with the Systemic Lupus
Activity Measure (SLAM).
Results
The cohort consisted of 59 women with mean age 31.3 ±
1.9 (range 13-68) years and mean disease duration 8 years
- 94.56 (range one month to 96 months). Hematological
modifications were manifested in 65 (75.6%). Anaemia was
more common maniferstation. After the investigations we
determined the following forms of anemia: the anemia of
chronic disease (ACD) n = 34 (57.6%), iron deficiency ane-
mia (IDA) n = 20 (33.9%), autoimmune hemolytic anemia
(AHA) n = 3 (5.1%) and other forms (anaemia of chronic
renal failure) causes n = 2 (3.4%). Leucopenia was present
at 18 (30.5%) patients, limphopenia at 19 (32.2%) patients
and thrombocitopenia at 13 (22.0%) patients. Assessment
of disease activity by SLAM showed that low disease activ-
ity was determined in 12 (20.3%) patients, moderate activ-
ity was found in 36 (61.0%) and high activity - in only 11
(18.6%) patients. This demonstrated that in examined
patients was predominant moderate activity 61.0% cases
and ACD 57.6%.
Conclusions
Anaemia is a common manifestation in SLE and it is
closely associated with moderate disease activity.
These associations are observed after one year of evo-
lution of systemic lupus erythematosus. Different levels
of anaemia may be used to monitor the disease activity.
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